J7312 HCPCS Level II code: Injection, dexamethasone, intravitreal implant, 0.1 mg
J7312 is the HCPCS code for “Injection, dexamethasone, intravitreal implant, 0.1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J7312Injection, dexamethasone, intravitreal implant, 0.1 mg
Short description: Dexamethasone intra implant
HCPCS · United States
Medicare details
The indicators CMS publishes with J7312 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2011
Where J7312 sits
- 1J codesDrugs administered other than orally
- 2Active code J7312Injection, dexamethasone, intravitreal implant, 0.1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J7312 mean?
J7312 is the HCPCS code for “Injection, dexamethasone, intravitreal implant, 0.1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J7312?
CMS lists J7312’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7312
All J codesJ7306Levonorgestrel (contraceptive) implant system, including implants and suppliesJ7307Etonogestrel (contraceptive) implant system, including implant and suppliesJ7308Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)J7309Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gramJ7310Ganciclovir, 4.5 mg, long-acting implantJ7311Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mgJ7313Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mgJ7314Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mgJ7315Mitomycin, ophthalmic, 0.2 mgJ7316Injection, ocriplasmin, 0.125 mgJ7318Hyaluronan or derivative, durolane, for intra-articular injection, 1 mgJ7320Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg